Readers' Choice - Analytical

You are the judge! Please rank the finalists from 1st place to 4th place below.

Question Title

* 1. Please rank the articles in terms of how innovative / cutting-edge the content was.

	1. Most innovative	2	3	4. Least innovative
Improving Cell Manufacturing Outcomes Using In-Line Biomarker Monitoring	Improving Cell Manufacturing Outcomes Using In-Line Biomarker Monitoring 1. Most innovative	Improving Cell Manufacturing Outcomes Using In-Line Biomarker Monitoring 2	Improving Cell Manufacturing Outcomes Using In-Line Biomarker Monitoring 3	Improving Cell Manufacturing Outcomes Using In-Line Biomarker Monitoring 4. Least innovative
Development of Patient-Focused Commercial Specifications: Understanding Clinical Relevance and Criticality of Quality Attributes	Development of Patient-Focused Commercial Specifications: Understanding Clinical Relevance and Criticality of Quality Attributes 1. Most innovative	Development of Patient-Focused Commercial Specifications: Understanding Clinical Relevance and Criticality of Quality Attributes 2	Development of Patient-Focused Commercial Specifications: Understanding Clinical Relevance and Criticality of Quality Attributes 3	Development of Patient-Focused Commercial Specifications: Understanding Clinical Relevance and Criticality of Quality Attributes 4. Least innovative
Product Quality Attribute Shifts in Perfusion Systems	Product Quality Attribute Shifts in Perfusion Systems 1. Most innovative	Product Quality Attribute Shifts in Perfusion Systems 2	Product Quality Attribute Shifts in Perfusion Systems 3	Product Quality Attribute Shifts in Perfusion Systems 4. Least innovative
Emerging Strategies for Drug Product Comparability and Process Validation	Emerging Strategies for Drug Product Comparability and Process Validation 1. Most innovative	Emerging Strategies for Drug Product Comparability and Process Validation 2	Emerging Strategies for Drug Product Comparability and Process Validation 3	Emerging Strategies for Drug Product Comparability and Process Validation 4. Least innovative

Comments

Question Title

* 2. Please rank in terms of how presentable/trustworthy the article and data are.

	1. Most presentable/trustworthy	2	3	4. Least presentable/trustworthy
Improving Cell Manufacturing Outcomes Using In-Line Biomarker Monitoring	Improving Cell Manufacturing Outcomes Using In-Line Biomarker Monitoring 1. Most presentable/trustworthy	Improving Cell Manufacturing Outcomes Using In-Line Biomarker Monitoring 2	Improving Cell Manufacturing Outcomes Using In-Line Biomarker Monitoring 3	Improving Cell Manufacturing Outcomes Using In-Line Biomarker Monitoring 4. Least presentable/trustworthy
Development of Patient-Focused Commercial Specifications: Understanding Clinical Relevance and Criticality of Quality Attributes	Development of Patient-Focused Commercial Specifications: Understanding Clinical Relevance and Criticality of Quality Attributes 1. Most presentable/trustworthy	Development of Patient-Focused Commercial Specifications: Understanding Clinical Relevance and Criticality of Quality Attributes 2	Development of Patient-Focused Commercial Specifications: Understanding Clinical Relevance and Criticality of Quality Attributes 3	Development of Patient-Focused Commercial Specifications: Understanding Clinical Relevance and Criticality of Quality Attributes 4. Least presentable/trustworthy
Product Quality Attribute Shifts in Perfusion Systems	Product Quality Attribute Shifts in Perfusion Systems 1. Most presentable/trustworthy	Product Quality Attribute Shifts in Perfusion Systems 2	Product Quality Attribute Shifts in Perfusion Systems 3	Product Quality Attribute Shifts in Perfusion Systems 4. Least presentable/trustworthy
Emerging Strategies for Drug Product Comparability and Process Validation	Emerging Strategies for Drug Product Comparability and Process Validation 1. Most presentable/trustworthy	Emerging Strategies for Drug Product Comparability and Process Validation 2	Emerging Strategies for Drug Product Comparability and Process Validation 3	Emerging Strategies for Drug Product Comparability and Process Validation 4. Least presentable/trustworthy

Comments

Question Title

* 3. Please rank the articles in terms of how applicable and helpful they are.

	1. Most applicable / helpful	2	3	4. Least applicable / helpful
Improving Cell Manufacturing Outcomes Using In-Line Biomarker Monitoring	Improving Cell Manufacturing Outcomes Using In-Line Biomarker Monitoring 1. Most applicable / helpful	Improving Cell Manufacturing Outcomes Using In-Line Biomarker Monitoring 2	Improving Cell Manufacturing Outcomes Using In-Line Biomarker Monitoring 3	Improving Cell Manufacturing Outcomes Using In-Line Biomarker Monitoring 4. Least applicable / helpful
Development of Patient-Focused Commercial Specifications: Understanding Clinical Relevance and Criticality of Quality Attributes	Development of Patient-Focused Commercial Specifications: Understanding Clinical Relevance and Criticality of Quality Attributes 1. Most applicable / helpful	Development of Patient-Focused Commercial Specifications: Understanding Clinical Relevance and Criticality of Quality Attributes 2	Development of Patient-Focused Commercial Specifications: Understanding Clinical Relevance and Criticality of Quality Attributes 3	Development of Patient-Focused Commercial Specifications: Understanding Clinical Relevance and Criticality of Quality Attributes 4. Least applicable / helpful
Product Quality Attribute Shifts in Perfusion Systems	Product Quality Attribute Shifts in Perfusion Systems 1. Most applicable / helpful	Product Quality Attribute Shifts in Perfusion Systems 2	Product Quality Attribute Shifts in Perfusion Systems 3	Product Quality Attribute Shifts in Perfusion Systems 4. Least applicable / helpful
Emerging Strategies for Drug Product Comparability and Process Validation	Emerging Strategies for Drug Product Comparability and Process Validation 1. Most applicable / helpful	Emerging Strategies for Drug Product Comparability and Process Validation 2	Emerging Strategies for Drug Product Comparability and Process Validation 3	Emerging Strategies for Drug Product Comparability and Process Validation 4. Least applicable / helpful

Comments

Question Title

* 4. In the field below, please tell us which article you ranked the highest overall and why. For instance, you might highlight the strategy or process that you found most innovative, summarize the information that you found most compelling, or explain how the article could be applicable to your current and future projects.

Question Title

* 5. As a thank you – you will be entered to win one of six complimentary registrations for the 2021 BioProcess International Conference and Exhibition delivered virtually September 20-30, 2021 ( a $1,250 value. New registrations only). Just provide us with the following information:

Name

Company

Address

Address 2

City/Town

ZIP/Postal Code

Country

Email Address

Phone Number